Shopping Cart 0
Cart Subtotal
USD 0

Queen Mary University of London - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 250

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 750
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Summary

Queen Mary University of London (Queen Mary), formerly Queen Mary and Westfield College, a subsidiary of University of London, is a research university that offers undergraduate and postgraduate education; and research programs. The university provides graduation and education services in areas of astrophysics, biological and chemical sciences, business and management, comparative literature, computer science, drama, economics and finance; electronic engineering, english, film studies, law, linguistics, materials, mathematical sciences and others. It also provides national research assessments and research funding programs. The university provides education services to students in the UK and abroad. Queen Mary is headquartered in London, the UK.

Queen Mary University of London-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

Queen Mary University of London, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Queen Mary University of London, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

Queen Mary University of London, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Queen Mary University of London, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

Queen Mary University of London, Medical Devices Deals, 2012 to YTD 2018 10

Queen Mary University of London, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11

Queen Mary University of London, Pharmaceuticals & Healthcare, Deal Details 12

Partnerships 12

Queen Mary University of London Enters into Research Agreement with Takeda Pharma 12

Cambridge University, Imperial College London, King's College London, Queen Mary University London, University College London and Oxford University Enter into Research and Development Agreement with Pfizer 13

Cancer Research Technology Enters Into Co-Development Agreement With ADC Therapeutics For Antibody Drug Conjugates 15

BioInvent And Cancer Research Technology Enter Into Co-Development Agreement With Queen Mary, University of London 17

MRC Technology Enters Into Drug Discovery Agreement With Queen Mary University 18

Licensing Agreements 19

MultiVir Enters into Licensing Agreement with Queen Mary University of London 19

BioMoti Enters into Licensing Agreement with Queen Mary University of London 20

Acquisition 21

Retroscreen Virology Acquires Activiomics for USD6.7 Million 21

Queen Mary University of London-Key Competitors 23

Queen Mary University of London-Key Employees 24

Queen Mary University of London-Locations And Subsidiaries 25

Head Office 25

Other Locations & Subsidiaries 25

Recent Developments 26

Strategy And Business Planning 26

Sep 19, 2018: Cancer Research UK launches new research hub for biotherapeutics 26

Government and Public Interest 27

Sep 12, 2018: Study links common arthritis drug azathioprine to skin cancer 27

Aug 26, 2018: Blood pressure medications and statins found to provide long-term cardiovascular benefits 28

Aug 26, 2018: Long-term cardiovascular benefits following statins and blood pressure trial 29

Jun 06, 2018: New lab technology could reveal treatments for muscle-wasting disease 31

Feb 27, 2018: Switching on survival signalling to drive drug resistance 33

Feb 06, 2018: Research projected launched to crack aspirin's anti-cancer properties 34

Feb 05, 2018: Multinational companies continue to produce unregulated antibiotics in India 35

Dec 11, 2017: Weakness discovered in most common childhood brain cancer 36

Nov 21, 2017: Drug could put an end to transplant rejection 37

Jul 14, 2017: Queen Mary University of London: Awarded GBP8.6m for global health research 38

Feb 07, 2017: NattoPharma Named Partner For Horizon 2020 EU Research Grant 39

Product News 40

Dec 14, 2017: Groundbreaking gene therapy trial set to cure hemophilia 40

Mar 05, 2018: Aspirin helps treat tuberculous meningitis 42

Feb 16, 2018: New printing technique uses cells and molecules to recreate biological structures 43

Appendix 44

Methodology 44

About GlobalData 44

Contact Us 44

Disclaimer 44


List Of Figure

List of Figures

Queen Mary University of London, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Queen Mary University of London, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Queen Mary University of London, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Queen Mary University of London, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Queen Mary University of London, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Queen Mary University of London, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7

Queen Mary University of London, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Queen Mary University of London, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

Queen Mary University of London, Medical Devices Deals, 2012 to YTD 2018 10


List Of Table

List of Tables

Queen Mary University of London, Pharmaceuticals & Healthcare, Key Facts 2

Queen Mary University of London, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Queen Mary University of London, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

Queen Mary University of London, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Queen Mary University of London, Deals By Therapy Area, 2012 to YTD 2018 9

Queen Mary University of London, Medical Devices Deals, 2012 to YTD 2018 10

Queen Mary University of London, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11

Queen Mary University of London Enters into Research Agreement with Takeda Pharma 12

Cambridge University, Imperial College London, King's College London, Queen Mary University London, University College London and Oxford University Enter into Research and Development Agreement with Pfizer 13

Cancer Research Technology Enters Into Co-Development Agreement With ADC Therapeutics For Antibody Drug Conjugates 15

BioInvent And Cancer Research Technology Enter Into Co-Development Agreement With Queen Mary, University of London 17

MRC Technology Enters Into Drug Discovery Agreement With Queen Mary University 18

MultiVir Enters into Licensing Agreement with Queen Mary University of London 19

BioMoti Enters into Licensing Agreement with Queen Mary University of London 20

Retroscreen Virology Acquires Activiomics for USD6.7 Million 21

Queen Mary University of London, Key Competitors 23

Queen Mary University of London, Key Employees 24

Queen Mary University of London, Subsidiaries 25

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

Queen Mary University of London, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.